nonprofit logo

Arrivederci Ald

Learn about this cause: Is it Legit? Do I like the mission? What is the CEO's salary?

EIN: 834665739 ✦ Houston, TX ✦ Designated as a 501(c)(3)

Shop smarter and support your favorite cause at the same time! With the Give Freely browser extension, you'll automatically save money with coupons, and partner stores will donate to your chosen charity - at no extra cost to you. Start giving back with a single click. It's safe, free, and spam-free, guaranteed!

Overview

What is Arrivederci Ald?

Arrivederci Ald is a nonprofit organization headquartered in Houston, Texas, specifically at 1324 South Blvd, 77006. Their primary mission is to identify and fund scientific and medical research aimed at developing more effective treatments and potentially finding a cure for Adrenoleukodystrophy (ALD) and Adrenoleukodystrophy and Adrenomyeloneuropathy (AMN), two related neurological disorders. By supporting research, Arrivederci Ald seeks to contribute to advancing our understanding of these conditions and ultimately improving the lives of those affected.


Official website here: www.arrivederciald.org

Is Arrivederci Ald legitimate?

Arrivederci Ald is a legitimate nonprofit organization registered as a 501(c)(3) entity. Arrivederci Ald submitted a form 990, which is a tax form used by tax-exempt organizations in the U.S., indicating its operational transparency and adherence to regulatory requirements. Donations to this organization are tax deductible.


Heare are some key statistics you may want to consider:

Executive Compensation: $0
Professional Fundraising Fees: $0
Other Salaries and Wages: $0

For more financial information, click here


Official website here: www.arrivederciald.org

What is the mission statement of Arrivederci Ald?

Arrivederci Ald is an organization primarily focused on identifying and funding scientific and medical research. Their ultimate goal is to discover more effective treatments and ultimately find a cure for Adrenoleukodystrophy (ALD) and Adrenomyeloneuropathy (AMN), two related neurological disorders. By funding research, Arrivederci Ald aims to contribute significantly to the advancement of treatments and potential cures for these debilitating diseases. The organization's efforts are dedicated to improving the lives of individuals and families affected by these conditions.


Official website here: www.arrivederciald.org

Who is the CEO of Arrivederci Ald?

Frances Broussard is the President of Arrivederci Ald.


Official website here: www.arrivederciald.org

What is the revenue of Arrivederci Ald?

Arrivederci Ald's revenue in 2022 was $279,030.


Official website here: www.arrivederciald.org

Who are the executives of Arrivederci Ald and what are their salaries?


Here are 5 key members and their salaries:


Frances Broussard (President)
  • Compensation: $0
  • Related: $0
  • Other: $0
Patrick Broussard (Treasurer)
  • Compensation: $0
  • Related: $0
  • Other: $0
Vincent Broussard (Director)
  • Compensation: $0
  • Related: $0
  • Other: $0
David Denenburg (Director)
  • Compensation: $0
  • Related: $0
  • Other: $0
Mary Mccormick (Director)
  • Compensation: $0
  • Related: $0
  • Other: $0


Official website here: www.arrivederciald.org

Where can I find the form 990 for Arrivederci Ald?

Arrivederci Ald's most recent form 990 was submitted in 2022 and can be accessed here.


Official website here: www.arrivederciald.org

Learn more at the official website: www.arrivederciald.org

Mission Statement of Arrivederci Ald

Arrivederci Ald is an organization dedicated to identifying and funding scientific and medical research with the aim of developing more effective treatments and ultimately finding a cure for Adrenoleukodystrophy (ALD) and Adrenomyeloneuropathy (AMN). This nonprofit is committed to making significant strides in the field of ALD and AMN research, recognizing the vital role such advancements play in improving the lives of those affected by these diseases. Arrivederci Ald's mission is to serve as a catalyst, connecting researchers and medical professionals to ensure that the most promising studies receive the necessary funding and support to progress towards a solution.

Shop smarter and support your favorite cause with the Give Freely browser extension. Save money with coupons and donate to charity with a single click. Download now!

Impact




October, 2024

Arrivederci Ald plays a crucial role in advancing the understanding and treatment of adrenoleukodystrophy (ALD) and adrenomyeloneuropathy (AMN). By identifying and funding scientific and medical research, the organization drives progress towards more effective therapies and potential cures for these debilitating conditions.

The impact of Arrivederci Ald extends beyond financial support; it fosters collaboration among researchers, clinicians, and institutions dedicated to ALD/AMN. By catalyzing innovative studies and experiments, the organization helps to bridge gaps in current knowledge and treatment options, ultimately benefiting patients and their families.

Through its commitment to research, Arrivederci Ald not only raises awareness about ALD and AMN but also empowers the scientific community to explore new avenues for treatment. This proactive approach can lead to breakthroughs that may significantly enhance the quality of life for those affected by these disorders.

Furthermore, Arrivederci Ald serves as a vital advocate for patients, raising awareness about the challenges they face and the need for more robust research funding. By mobilizing resources and community support, the organization amplifies the collective voice calling for advancements in medical understanding and therapeutic options.

In summary, Arrivederci Ald's impact is felt in the realms of research, awareness, collaboration, and advocacy, all of which contribute to a brighter future for individuals impacted by ALD and AMN.




This information is meant to be a general summary of Arrivederci Ald. Please take the time to review official sources before making any decisions based upon the content provided here.


Financials

This financial information is from Propublica.

Revenue
$279,030 (2022)
Expenses
$92,514 (2022)
Efficiency

Other financial information:

This information is from the most recently submitted tax form from this organization, which was in 2022.

  • Investment Income: $9
  • Gross Receipts: $279,030

Assets and Liabilities:

  • Total Assets: $260,429
  • Total Liabilities: $0
  • Net Assets: $260,429

Want to help this charity, for free? You can click here to learn more about Give Freely

Organization Details

Founding Year

2019

Principal Officer

Frances Broussard

Main Address

1324 SOUTH BLVD, HOUSTON, TX, 77006

NTEE Category

Code: T12 - Philanthropy

If you are a representative of Arrivederci Ald and wish to learn more about how Give Freely can help you raise funds, please click here: https://givefreely.com/nonprofits/. Our services are offered at no cost to your organization.